Sensus Healthcare Reports Q4/FY25 Loss, Projects 2026 Profitability Driven by 300% Reimbursement Increase

summarizeSummary

Sensus Healthcare reported significant losses for Q4 and full-year 2025, but provided optimistic 2026 guidance, expecting full-year profitability driven by a 300% increase in CMS reimbursement for its SRT technology.

check_boxKey Events

• Q4 & FY 2025 Financial Performance

  Sensus Healthcare reported a net loss of $3.2 million for Q4 2025 and $7.7 million for the full year 2025, a significant decline from net income in the prior year, with revenues also decreasing substantially.

• New CMS Reimbursement Codes

  Dedicated CPT codes for SRT to treat non-melanoma skin cancer, effective January 1, 2026, include a 300% per-fraction increase to the delivery code, providing significant reimbursement certainty.

• 2026 Outlook and Profitability Target

  Management expects sequential-quarter revenue growth in Q1 2026 and aims for full-year profitability, leveraging the enhanced reimbursement and a diversified customer base.

• SRT System Shipments

  The company shipped 14 SRT systems in Q4 2025, an increase from Q3, notably without any contribution from its historically largest customer, indicating successful customer diversification.

auto_awesomeAnalysis

Sensus Healthcare's latest 8-K reveals a challenging 2025 with substantial revenue declines and a shift to net losses for both the fourth quarter and the full year. However, the filing's market-moving importance stems from the highly positive forward guidance for 2026. The company highlights the new CMS Physician Fee Schedule Final Rule, which provides a significant 300% per-fraction increase to the delivery code for its Superficial Radiotherapy (SRT) technology, effective January 1, 2026. This reimbursement certainty, coupled with management's expectation of sequential revenue growth in Q1 and a target for full-year profitability in 2026, signals a potential turnaround. Investors will likely focus on the impact of these new reimbursement rates and the company's ability to execute on its profitability objective, especially given its stable cash position and efforts to diversify its customer base.